sulfur hexafluoride has been researched along with Coronary Disease in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 9 (81.82) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Keituqwa Yáñez, I; Nicolás Franco, S; Pinar Bermúdez, E | 1 |
| Kuecherer, H | 1 |
| Angermann, CE; Jung, PH | 1 |
| Almería, C; Aubele, A; Luis Rodrigo, J; Luis Zamorano, J; Pérez de Isla, L; Serra, V | 1 |
| Becher, H; Timperley, J | 1 |
| Chelliah, R; Senior, R | 1 |
| Cosyns, B; Droogmans, S; Lancellotti, P; Schoors, D; Van Camp, G; Weytjens, C | 1 |
| Cachard, C; Durning, B; Dydenko, I; Friboulet, D; Jamal, F | 1 |
| Broillet, A; Puginier, J; Schneider, M; Ventrone, R | 1 |
| Amyot, R; L'Abbate, A; Morales, MA; Rovai, D | 1 |
| Agati, L; Andersson, O; Bezante, G; Caidahl, K; Carlens, P; Guerret, P; Herregods, MC; Jenni, R; Kenny, A; la Rosee , K; Melcher, A; Senior, R; Svedenhag, J; Vanoverschelde, JL; Wandt, B; Widgren, BR; Williams, G | 1 |
5 review(s) available for sulfur hexafluoride and Coronary Disease
| Article | Year |
|---|---|
The added clinical value of second generation ultrasound contrast agents.
Topics: Acute Coronary Syndrome; Contrast Media; Coronary Disease; Echocardiography; Echocardiography, Stress; Humans; Image Enhancement; Myocardial Infarction; Phospholipids; Sulfur Hexafluoride | 2003 |
Clinical benefits of using second generation ultrasound contrast agents in stress echocardiography.
Topics: Albumins; Clinical Competence; Clinical Trials as Topic; Contrast Media; Coronary Disease; Cost-Benefit Analysis; Echocardiography, Stress; Fluorocarbons; Humans; Phospholipids; Sulfur Hexafluoride | 2003 |
Myocardial contrast echocardiography in the assessment of patients with chronic coronary artery disease.
Topics: Albumins; Blood Volume; Chronic Disease; Contrast Media; Coronary Circulation; Coronary Disease; Echocardiography; Fluorocarbons; Humans; Microcirculation; Phospholipids; Polysaccharides; Prognosis; Sulfur Hexafluoride | 2003 |
An update on contrast echocardiography.
Topics: Clinical Trials as Topic; Contraindications; Contrast Media; Coronary Disease; Echocardiography, Stress; Electrocardiography; Humans; Microbubbles; Multicenter Studies as Topic; Phospholipids; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Sulfur Hexafluoride; Tomography, Emission-Computed, Single-Photon; Ultrasonography; United States; United States Food and Drug Administration; Ventricular Function, Left | 2009 |
Clinical experience with SonoVue in myocardial perfusion imaging.
Topics: Angioplasty, Balloon, Coronary; Contrast Media; Coronary Disease; Echocardiography, Doppler, Color; Humans; Image Enhancement; Male; Middle Aged; Perfusion; Sensitivity and Specificity; Sulfur Hexafluoride; Tomography, Emission-Computed, Single-Photon | 2000 |
1 trial(s) available for sulfur hexafluoride and Coronary Disease
| Article | Year |
|---|---|
Enhanced left ventricular endocardial border delineation with an intravenous injection of SonoVue, a new echocardiographic contrast agent: A European multicenter study.
Topics: Aged; Confidence Intervals; Contrast Media; Coronary Disease; Cross-Over Studies; Dose-Response Relationship, Drug; Echocardiography; Female; Humans; Injections, Intravenous; Male; Middle Aged; Phospholipids; Prospective Studies; Radiographic Image Enhancement; Reference Values; Sensitivity and Specificity; Sulfur Hexafluoride; United Kingdom | 2000 |
5 other study(ies) available for sulfur hexafluoride and Coronary Disease
| Article | Year |
|---|---|
Use of echo-contrast in the diagnosis of coronary fistula rupture.
Topics: Aged; Aneurysm, False; Contrast Media; Coronary Angiography; Coronary Disease; Echocardiography; Emergencies; Humans; Male; Pericardial Effusion; Phospholipids; Rupture, Spontaneous; Sulfur Hexafluoride; Vascular Fistula | 2018 |
Optimal use of contrast echo in daily practice: what do we need?
Topics: Contrast Media; Coronary Disease; Echocardiography; Europe; Humans; Image Enhancement; Infusion Pumps; Phospholipids; Practice Patterns, Physicians'; Sulfur Hexafluoride | 2003 |
Analysis of regional wall motion during contrast-enhanced dobutamine stress echocardiography: effect of contrast imaging settings.
Topics: Aged; Contrast Media; Coronary Angiography; Coronary Disease; Echocardiography, Stress; Female; Humans; Image Processing, Computer-Assisted; Linear Models; Male; Myocardial Contraction; Phospholipids; Prospective Studies; Sensitivity and Specificity; Sulfur Hexafluoride; Tomography, Emission-Computed, Single-Photon | 2009 |
An autoregressive model-based method for contrast agent detection in ultrasound radiofrequency images.
Topics: Contrast Media; Coronary Disease; Echocardiography; Humans; Image Processing, Computer-Assisted; Phantoms, Imaging; Phospholipids; Radio Waves; Signal Processing, Computer-Assisted; Sulfur Hexafluoride | 2005 |
Assessment of myocardial perfusion by intermittent harmonic power Doppler using SonoVue, a new ultrasound contrast agent.
Topics: Animals; Contrast Media; Coronary Circulation; Coronary Disease; Echocardiography, Doppler; Phantoms, Imaging; Phospholipids; Sulfur Hexafluoride; Swine; Swine, Miniature | 1998 |